Cingulate, the clinical stage biopharmaceutical company, faced a significant exodus of officers and board members this week. The retiring chief financial officer, Louis Van Horn, stepped down two days prior…
Ensysce Biosciences experienced a surge in shares after receiving feedback from the Food and Drug Administration (FDA) regarding clinical-trial approaches for one of their pain medication products. The San Diego-based…
by Denny Jacob Quince Therapeutics announced its plans to move forward with trials on EryDex after the U.S. Food and Drug Administration (FDA) lifted the hold on EryDel's investigational new…
Eli Lilly & Co. (LLY) has reported significant progress in a Phase 3 clinical trial of their treatment for a specific type of non-small cell lung cancer. The trial, called…
Shares of ZyVersa Therapeutics saw a 9.2% increase in trading today following the announcement that the company has been granted a patent for its kidney disease treatment, VAR 200, by…